Advertisement · 728 × 90
#
Hashtag
#Hope_Therapeutics
Advertisement · 728 × 90
Preview
HOPE Therapeutics Receives Approval for Dura Medical Acquisition to Enhance Mental Health Services HOPE Therapeutics has secured final approval from Florida's healthcare agency to acquire Dura Medical, enhancing mental health services across the state.

HOPE Therapeutics Receives Approval for Dura Medical Acquisition to Enhance Mental Health Services #United_States #NRx_Pharmaceuticals #Florida #Hope_Therapeutics #Dura_Medical

0 0 0 0
Preview
HOPE Therapeutics and NRx Pharmaceuticals Acquire Interest in Cohen and Associates to Expand Psychiatry Clinics HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. have announced their acquisition of a 49% interest in Cohen and Associates to enhance their interventional psychiatry clinic network.

HOPE Therapeutics and NRx Pharmaceuticals Acquire Interest in Cohen and Associates to Expand Psychiatry Clinics #United_States #Miami #NRx_Pharmaceuticals #Hope_Therapeutics #Cohen_and_Associates

0 0 0 0
Preview
NRx Pharmaceuticals and HOPE Therapeutics Form Strategic Partnership with astr Partners for Investor Relations NRx Pharmaceuticals and HOPE Therapeutics have partnered with astr partners to enhance investor relations, focusing on life sciences to support neuropsychiatry therapies.

NRx Pharmaceuticals and HOPE Therapeutics Form Strategic Partnership with astr Partners for Investor Relations #USA #NRx_Pharmaceuticals #Wilmington #Hope_Therapeutics #astr_partners

0 0 0 0
Preview
NRx Pharmaceuticals and HOPE Therapeutics to Shine at Neuro Perspectives Conference NRx Pharmaceuticals and HOPE Therapeutics will showcase their latest advancements at the H.C. Wainwright Neuro Perspectives Conference, June 2025.

NRx Pharmaceuticals and HOPE Therapeutics to Shine at Neuro Perspectives Conference #United_States #NRx_Pharmaceuticals #Wilmington #Hope_Therapeutics #Neuro_Perspectives

0 0 0 0
Preview
NRx Pharmaceuticals and HOPE Therapeutics Set for Key Presentation at Wall Street Conference 2025 NRx Pharmaceuticals is gearing up for a significant presentation at the Wall Street Conference on May 21, 2025. Key updates on drug approvals and acquisitions will be discussed.

NRx Pharmaceuticals and HOPE Therapeutics Set for Key Presentation at Wall Street Conference 2025 #USA #NRx_Pharmaceuticals #Palm_Beach #Hope_Therapeutics #Ketamine

0 0 0 0
Preview
NRx Pharmaceuticals Reports First Quarter 2025 Financial Results and Advances Mental Health Initiatives NRx Pharmaceuticals shares a corporate update and financial results for Q1 2025, emphasizing the progress on FDA approvals and new treatment initiatives.

NRx Pharmaceuticals Reports First Quarter 2025 Financial Results and Advances Mental Health Initiatives #United_States #NRx_Pharmaceuticals #Wilmington #NRX-100 #Hope_Therapeutics

0 0 0 0
Preview
HOPE Therapeutics Secures $7.8 Million for Expansion of Psychiatry Clinics Nationwide HOPE Therapeutics has signed a $7.8 million debt financing term sheet to advance its acquisition of interventional psychiatry clinics, enhancing mental health care access.

HOPE Therapeutics Secures $7.8 Million for Expansion of Psychiatry Clinics Nationwide #United_States #mental_health #Miami #NRx_Pharmaceuticals #Hope_Therapeutics

0 0 0 0
Preview
HOPE Therapeutics and NRx Pharmaceuticals Announce Major Step in Transforming Mental Health Care with Kadima Institute Acquisition The acquisition of Kadima Neuropsychiatry Institute marks a landmark development for HOPE Therapeutics aimed at revolutionizing mental health treatment through cutting-edge methodologies.

HOPE Therapeutics and NRx Pharmaceuticals Announce Major Step in Transforming Mental Health Care with Kadima Institute Acquisition #USA #NRx_Pharmaceuticals #La_Jolla #Hope_Therapeutics #Kadima_Institute

0 0 0 0
Preview
HOPE Therapeutics and NRx Pharmaceuticals to Host Exclusive Investor Event at Mar-A-Lago Club On May 8, 2025, HOPE Therapeutics and NRx Pharmaceuticals will gather investors at the Mar-A-Lago Club to discuss key initiatives and clinical progress.

HOPE Therapeutics and NRx Pharmaceuticals to Host Exclusive Investor Event at Mar-A-Lago Club #United_States #Investor_Event #NRx_Pharmaceuticals #Palm_Beach #Hope_Therapeutics

0 0 0 0
Preview
NRx Pharmaceuticals and HOPE Therapeutics to Host Digital Fireside Chat on Innovative Psychiatric Treatments NRx Pharmaceuticals and HOPE Therapeutics will engage in a fireside chat, discussing groundbreaking mental health treatments on April 22, 2025.

NRx Pharmaceuticals and HOPE Therapeutics to Host Digital Fireside Chat on Innovative Psychiatric Treatments #USA #NRx_Pharmaceuticals #Wilmington #Hope_Therapeutics #psychiatric_treatments

0 0 0 0
Preview
HOPE Therapeutics and NRx Pharmaceuticals Secure Strategic Funding for Expanding Mental Health Services HOPE Therapeutics, alongside NRx Pharmaceuticals, has finalized a strategic investment to expand its mental health services for treating severe depression and PTSD.

HOPE Therapeutics and NRx Pharmaceuticals Secure Strategic Funding for Expanding Mental Health Services #United_States #mental_health #Miami #NRx_Pharmaceuticals #Hope_Therapeutics

0 0 0 0
Preview
HOPE Therapeutics and NRx Pharmaceuticals Acquire Dura Medical to Expand Psychiatry Clinic Network HOPE Therapeutics, Inc. and NRx Pharmaceuticals announce the acquisition of Dura Medical to enhance their interventional psychiatry services across Florida, aiding mental health treatment.

HOPE Therapeutics and NRx Pharmaceuticals Acquire Dura Medical to Expand Psychiatry Clinic Network #USA #Miami #Hope_Therapeutics #Dura_Medical #Interventional_Psychiatry

0 0 0 0
Preview
HOPE Therapeutics and NRx Pharmaceuticals Expand Global Psychiatry Network with Neurospa Acquisition HOPE Therapeutics, Inc. partners with Neurospa to enhance its interventional psychiatry clinics, expanding its reach in mental health care.

HOPE Therapeutics and NRx Pharmaceuticals Expand Global Psychiatry Network with Neurospa Acquisition #United_States #Miami #NRx_Pharmaceuticals #Hope_Therapeutics #Neurospa

0 0 0 0
Preview
NRx Pharmaceuticals Announces Financial Results and Strategic Advances in Depression Treatments NRx Pharmaceuticals reports its financial results for Q4 and the full year of 2024, unveiling key developments in depression treatment strategies. The company is advancing its drug application process and expanding its psychiatric care network.

NRx Pharmaceuticals Announces Financial Results and Strategic Advances in Depression Treatments #USA #NRx_Pharmaceuticals #Wilmington #NRX-100 #Hope_Therapeutics

0 0 0 0
Preview
HOPE Therapeutics Forms Strategic Alliance with BTIG for Clinic Expansion Plans HOPE Therapeutics has enlisted BTIG as a financial advisor to expand its global clinic network, focusing on mental health treatments combining innovative therapies.

HOPE Therapeutics Forms Strategic Alliance with BTIG for Clinic Expansion Plans #United_States #Miami #NRx_Pharmaceuticals #Hope_Therapeutics #BTIG

0 0 0 0
Preview
NRx Pharmaceuticals Strengthens Partnership with Anson Funds Through $8.9 Million Financial Deal NRx Pharmaceuticals has reached a significant financing agreement with Anson Funds, raising $8.9 million to advance its drug development and support operations through 2026.

NRx Pharmaceuticals Strengthens Partnership with Anson Funds Through $8.9 Million Financial Deal #United_States #NRx_Pharmaceuticals #Wilmington #Hope_Therapeutics #Anson_Funds

0 0 0 0
Preview
HOPE Therapeutics Partners with NRx Pharmaceuticals for $27 Million Clinic Acquisition HOPE Therapeutics, in collaboration with NRx Pharmaceuticals, secures a $27 million investment to enhance its network of interventional psychiatry clinics focusing on mental health care.

HOPE Therapeutics Partners with NRx Pharmaceuticals for $27 Million Clinic Acquisition #mental_health #Miami #US #NRx_Pharmaceuticals #Hope_Therapeutics

0 0 0 0
Preview
NRx Pharmaceuticals Welcomes New Board Members to Enhance Company Growth and Innovation NRx Pharmaceuticals has appointed new members to its Board of Directors, enhancing its leadership as it develops innovative therapeutics for mental health disorders.

NRx Pharmaceuticals Welcomes New Board Members to Enhance Company Growth and Innovation #United_States #NRx_Pharmaceuticals #Wilmington #Hope_Therapeutics #Michael_Taylor

0 0 0 0
Preview
HOPE Therapeutics to Feature Dr. David Feifel on CNN's Special K Ketamine Program HOPE Therapeutics and NRx Pharmaceuticals highlight the significance of ketamine treatment, featuring Dr. David Feifel on CNN's latest program.

HOPE Therapeutics to Feature Dr. David Feifel on CNN's Special K Ketamine Program #United_States #Miami #NRx_Pharmaceuticals #Hope_Therapeutics #Dr._David_Feifel

0 0 0 0
Preview
HOPE Therapeutics and NRx Pharmaceuticals Host Investor Workshop at Mar-A-Lago Club HOPE Therapeutics and NRx Pharmaceuticals recently held an investor workshop at Mar-A-Lago, focusing on expanding interventional psychiatry practices for treating mental health.

HOPE Therapeutics and NRx Pharmaceuticals Host Investor Workshop at Mar-A-Lago Club #United_States #NRx_Pharmaceuticals #Palm_Beach #Hope_Therapeutics #Mar-A-Lago

0 0 0 0
Preview
Keynote Address on Advances in Treating Suicidal Depression at Neuroscience Forum At the upcoming Neuroscience Innovation Forum, experts will discuss innovative treatments combining ketamine and other modalities for resisting depression and PTSD.

Keynote Address on Advances in Treating Suicidal Depression at Neuroscience Forum #United_States #San_Francisco #NRx_Pharmaceuticals #Hope_Therapeutics #Jonathan_Javitt

0 0 0 0
Preview
HOPE Therapeutics Partners with Smith & Sauer for $27 Million in Strategic Funding HOPE Therapeutics and NRx Pharmaceuticals are poised for growth with a $27 million infusion aimed at mental health clinic expansions and innovative drug developments.

HOPE Therapeutics Partners with Smith & Sauer for $27 Million in Strategic Funding #USA #Miami #NRx_Pharmaceuticals #Hope_Therapeutics #Smith_Sauer

0 0 0 0
Preview
HOPE Therapeutics Expands International Network with Dura Medical in Florida HOPE Therapeutics, a subsidiary of NRx Pharmaceuticals, plans to acquire Dura Medical, marking a significant expansion in Florida's mental health services.

HOPE Therapeutics Expands International Network with Dura Medical in Florida #USA #NRx_Pharmaceuticals #Florida #Hope_Therapeutics #Dura_Medical

0 0 0 0
Preview
HOPE Therapeutics to Conduct Investor Workshop at Mar-A-Lago Club for Acquisition Insights HOPE Therapeutics, a subsidiary of NRx Pharmaceuticals, is set to hold a workshop for qualified institutional investors in January 2025, detailing its acquisition plans in psychiatry.

HOPE Therapeutics to Conduct Investor Workshop at Mar-A-Lago Club for Acquisition Insights #USA #Miami #NRx_Pharmaceuticals #Hope_Therapeutics #Mar-A-Lago

0 0 0 0
Preview
Hope Therapeutics Welcomes Kadima Neuropsychiatry Institute to Global Network of Psychiatry Clinics Hope Therapeutics announces the acquisition of Kadima Neuropsychiatry Institute, opening a pivotal chapter in mental health treatment focusing on PTSD and depression.

Hope Therapeutics Welcomes Kadima Neuropsychiatry Institute to Global Network of Psychiatry Clinics #United_States #NRx_Pharmaceuticals #La_Jolla #Hope_Therapeutics #Kadima_Neuropsychiatry

0 0 0 0